Aim: Non-insulin-dependent diabetic mellitus model rats, Otsuka-Long-Evans-Tokushima-Fatty (OLETF), develop diabetic nephropathy presenting with mesangial expansion leading to glomerular sclerosis and thickening of the glomerular basement membrane (GBM), especially in elderly males. The effects of sex hormones and castration on the incidence of diabetes mellitus (DM) have been studied in this strain rat. However, there have been no detailed studies on the effects of castration and sex hormone in the development of diabetic nephropathy. Methods: In this study we examine the effect of castration or estrogen on the development of glomerular injury in OLETF rats. Thirty male OLETF rats and 10 male long-Evans Tokushima Otsuka (LETO) rats as a normal control were used. OLETF rats were divided into three groups: group 1 received sham-operation, group 2 was castrated at 6 weeks, and group 3 was administered 0.1 mg estrogen subcutaneously once a month from 6 weeks to 58 weeks of age and LETO rats were assigned to group 4. Body weight, urinary protein and fasting blood glucose, serum albumin and other serum constituents were investigated every 12 weeks from 12 weeks to 60 weeks of age. In groups 1–3, glucose tolerance test was performed at 38 weeks. Each group was studied morphologically at the end of the experiment (60 weeks of age). Results: Castration attenuated proteinuria and glomerular sclerosis accompanied by an amelioration of glucose tolerance, a decrease in mesangial expansion and an attenuation of the GBM thickening. In contrast, although estrogen equally ameliorated glucose tolerance and attenuated the mesangial expansion and the GBM thickening, estrogen failed to attenuate proteinuria and glomerulosclerosis. A significant increase in glomerular tuft volume, and serum levels of growth hormone, total cholesterol and triglycerides was observed in the estrogen-treated rats as compared with the castrated rats. Conclusion: Besides the mechanisms involved in the development of diabetic nephropathy, other mechanisms may be involved and contribute to the development of glomerulosclerosis in the estrogen-treated rats, leading to a difference in glomerular injury between the castrated and estrogen-treated OLETF rats.

Keywords:
Castration, Estrogen, Glomerulosclerosis, Diabetes mellitus, Rat
1.
Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T: Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) Strain. Diabetes 1992;41:1422–1428.
2.
Clark JB, Palmer CJ, Shaw WN: The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 1983;173:68–75.
3.
Boucher DW, Hayashi K, Rosenthal J, Notkins AL: Virus-induced diabetes mellitus. III. Influence of the sex and strain of the host. J Infect Dis 1975;131:462–466.
4.
Ikeda H, Shino A, Matsuo T, Iwatsuka H, Suzuoki Z: A new genetically obese-hyperglycemic rat (Wistar fatty). Diabetes 1981;30:1045–1050.
5.
Shi K, Mizuno A, Sano T, Ishida K, Shima K: Sexual difference in the incidence of diabetes mellitus in Otsuka-Long-Evans-Tokushima-Fatty rats: Effects of castration and sex hormone replacement on its incidence. Metabolism 1994;43:1214–1220.
6.
Hirashima T, Kawano K, Mori S, Natori T: The influence of testosterone on the spontaneous hyperglycaemic Otsuka Long-Evans Tokushima Fatty (OLETF) rat. Int Diabetes 1996;4:85–92.
7.
Fukuzawa Y, Watanabe Y, Inaguma D, Hotta N: Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state. J Lab Clin Med 1996;128:568–578.
8.
Ohtsuka N, Sakemi T, Shouno Y, Morito F: Attenuating effect of castration or estrogen administration on glomerular injury in adriamycin-induced nephropathy of rats. Nephrology 1996;2:45–52.
9.
Fujita Y: Color reaction between pyrogallol red-molybdenum (VI) complex and protein. Bunsekikagaku 1983;32:E379–386.
10.
Gornall AG, Bardawill CJ, David MM: Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949;177:751–761.
11.
Taussky HH: A microcolorimetric determination of creatinine in urine by Jaffe’s reaction. J Biol Chem 1954;208:853–861.
12.
Allain CC, Poon LS, Chan CS: Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470–475.
13.
Banauch D, Brummer W, Ebeling W, Metz H, Rindfrey H, Lang H, Leybold K, Rick W, Staudinger HJ: A glucose dehydrogenase for the determination of glucose concentrations in body fluids. J Clin Chem Clin Biochem 1975;13:101–107.
14.
Keizer H, Janssen GME, Menheere P, Kranenburg G: Changes in basal plasma testosterone, cortical, and dehydroepiandrosterone sulfate in previously untrained males and females preparing for a marathon. Int J Sports Med 1989;10:S139–S145.
15.
Raij L, Azar S, Keane W: Mesangial immune injury, hypertension,and progressive glomerular damage in Dahl rats. Kidney Int 1984;26:137–143.
16.
Sakemi T, Baba N: Castration attenuates proteinuria and glomerular injury in hyperlipidemic Imai rats. Nephron 1993;64:429–435.
17.
Suzuki D, Miyazaki M, Jinde K, Koji T, Yagame M, Endoh M, Nomoto Y, Sakai H: In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV colloagen in diabetic nephropathy. Kidney Int 1997;52:111–119.
18.
Weibel ER: Practical Methods for Biological Morphometry. Stereological Methods. London, Academic Press, 1979, vol 1, pp 1–145.
19.
Jensen EB, Gundersen HJG, Osterby R: Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 1979;115:19–23.
20.
Shoupe D, Lobo RA: The influence of androgens on insulin resistance. Fertil Steril 1984;41:385–388.
21.
Lewis JT, Foglia VG, Rodrigues RR: The effects of steroids on the incidence of diabetes in rats after subtotal pancreatectomy. Endocrinology 1950;46:111–121.
22.
Adler S: Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J Am Soc Nephrol 1994;5:1165–1172.
23.
Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143–1155.
24.
Bach LA, Cooper ME, Vranes D, Allen TJ, Rumble J, Jerums G: Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat. Diabetes Res 1994;27:27–38.
25.
Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989;36:626–635.
26.
EL Nahas M, Bassetta AH, Cope GH, Carpentier JE: Role of growth hormone in the development of experimental renal scarring. Kidney Int 1991;40:29–34.
27.
Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker GE: Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-1. Am J Pathol 1988;131:398–403.
28.
Doi T, Striker LJ, Gibson CC, Agodoa LYC, Brinster RL, Striker GE: Glomerular lesions in mice transgenic for growth hormone and insulin-like growth factor-1. 1. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 1990;137:541–552.
29.
Ohtsuka N, Sakemi T, Tomiyoshi Y, Morito F: Different effect of estrogen administration from castration on glomerular injury in unilaterally nephrectomized male Sprague-Dawley rats. Nephron 1997;77:445–451.
30.
Nakamura M, Ikeda Y, Mine M, Tomiyoshi Y, Sakemi T: Somatostatin analogue attenuates estrogen-induced augmentation of glomerular injury in spontaneous hypercholesterolemic female Imai rats. Nephron 2001;89:448–454.
31.
Cohen AM, Rosenmann E: Effect of the estrogen antagonist, tamoxifen, on development of glomerulosclerosis in the Cohen diabetic rat. Diabetes 1985;34:634–638.
32.
Rosenmann E, Yanko L, Cohen AM: Female sex hormone and nephropathy in Cohen diabetic rat (genetically selected sucrose-fed). Horm Metab Res 1984;16:11–16.
33.
Kasiske BL, O’Donnell MP, Cleary MP, Keane WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney int 1988;33:667–672.
34.
Greco F, Davis WA, Simon NM, Huang C, Huang C, Krumlovsky FA: Hypertension of chronic renal failure: Role of sodium and the renal pressor system. Kidney Int 1975;7:S176–S183.
35.
Gades MD, Stern JS, van Goor H, Nguyen D, Johnson PR, Kaysen GA: Estrogen accelerates the development of renal disease in female obese Zucker rats. Kidney Int 1998;53:130–135.
36.
Joles JA, van Goor Harry, Koomans HA: Estrogen induces glomerulosclerosis in analbuminemic rats. Kidney Int 1998;53:862–868.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.